Research recommendations information | Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer | Guidance | NICE

Research recommendations coming out of this guidance

Studies exploring the effectiveness of bevacizumab in people previously treated with a taxane and its effects on health-related quality of life.